8304
N. Takenaka et al. / Tetrahedron 58 (2002) 8299–8305
˚
999–1005. (e) Marazano, C.; LeGoff, M.; Fourrey, J.; Das,
B. C. J. Chem. Soc., Chem. Commun. 1981, 389–391.
(f) Raucher, S.; Bray, B. L. J. Org. Chem. 1985, 50,
3236–3237. (g) Kuehne, M. E.; Bornmann, W. G.; Earley,
W. G.; Marko, I. J. Org. Chem. 1986, 51, 2913–2927.
(h) Raucher, S.; Bray, B. L.; Lawrence, R. F. J. Am. Chem.
Soc. 1987, 109, 442–446. (i) Reding, M. T.; Fukuyama, T.
Org. Lett. 1999, 1, 973–976. Synthesis of (þ)-catharanthine
(65.0 mg, 0.46 mmol), dry powdered 4 A molecular sieve
(138.0 mg), and (S)-02,20-bis(3,5-di-tert-butyl-2-hydroxy-
benzylideneamino)-1,1 -binaphthyl chromium(III) trifluoro-
methanesulfonate (21.0 mg, 0.023 mmol). Acetone
(0.5 mL) was added to the flask and the reaction mixture
was stirred for 24 h at ambient temperature. The reaction
mixture was filtered through a short pad of silica gel and the
pad was rinsed with ethyl acetate. The crude reaction
mixture was concentrated in vacuo and then purified by
flash chromatography on silica gel (50% ethyl acetate in
hexanes) to give 77.9 mg (quant.) of the title compound, a
light yellow foam. 1H NMR (400 MHz, DMSO-d6, 1208C) d
(7.35, J¼16.0, 8.0 Hz, 2H), 7.18 (t, J¼8.0 Hz, 1H), 7.13 (d,
J¼8.0 Hz, 2H), 6.49 (dd, J¼16.0, 8.0 Hz, 1H), 6.41 (dd,
J¼12.0, 8.0 Hz, 1H), 5.03 (br s, 1H), 4.39 (m, 2H), 4.14 (m,
1H), 3.88 (m, 2H), 3.42 (br d, J¼8.0 Hz, 1H), 3.06 (br d,
J¼8.0 Hz, 1H), 2.91 (br s, 1H), 2.12 (t, J¼8 Hz, 1H), 1.68
(m, 1H); 13C NMR (100 MHz, DMSO-d6, 1208C) d 171.3,
152.3, 151.7, 150.9, 133.6, 130.2, 128.2, 124.0, 120.7, 61.7,
46.8, 46.4, 43.1, 42.0, 29.7, 26.6; HPLC analysis
(CHIRALPAKw AD, 75% iPrOH/hexanes, 1.0 mL/min,
254 nm; tr (minor)¼8.29, tr (major)¼12.51, 79% ee).
´
´
¨
via resolution: (j) Szantay, C.; Bolcskei, H.; Gacs-Baitz, E.
Tetrahedron 1990, 46, 1711–1732, and references cited
therein.
´
2. (a) Kuehne, M. E.; Marko, I. In Syntheses of Vinblastine-type
Alkaloids. The Alkaloids. Antitumor Bisindole Alkaloids from
Catharanthus roseus (L.); Brossi, A., Suffness, M., Eds.;
Academic: San Diego, 1990; Vol. 37, pp 77–131.
(b) Takayama, H.; Sakai, S. In Monoterpenoid Indole Alkaloid
Syntheses Utilizing Biomimetic Reactions. The alkaloids.
Chemistry and Biology; Cordell, G. A., Ed.; Academic: San
Diego, 1998; Vol. 50, pp 415–452.
3. (a) The Alkaloids. Antitumor Bisindole Alkaloids from
Catharanthus roseus (L.); Brossi, A., Suffness, M., Eds.;
Academic: San Diego, 1990; Vol. 37. (b) Popik, P.; Skolnick,
P. In Pharmacology of Ibogaine and Ibogaine-related
Alkaloids. The Alkaloids. Chemistry and Biology; Cordell,
G. A., Ed.; Academic: San Diego, 1999; Vol. 52, pp 197–231.
(c) Glick, S. D.; Maisonneuve, I. M.; Szumlinski, K. K. In
Mechanisms of Action of Ibogaine: Relevance to Putative
Therapeutic Effects and Development of a Safer Iboga
Alkaloid Congener. The Alkaloids; Alper, K. R., Glick, S. D.,
Cordell, G. A., Eds.; Academic: San Diego, 2001; Vol. 56,
pp 39–53.
3.4.2. General procedure for 7-formyl-7-methyl-2-aza-
bicyclo[2.2.2]oct-5-ene-2-carboxylic acid phenyl ester.
An oven-dried round-bottom flask containing a stir bar was
charged with 1,2-dihydropyridine (46.5 mg, 0.23 mmol),
0
˚
dry powdered 4 A molecular sieve (138.0 mg), (S)-2,20-
bis(3,5-di-tert-butyl-2-hydroxybenzylideneamino)-1,1 -
binaphthyl chromium(III) SbF6 (23.0 mg, 0.023 mmol), and
acetone (0.5 mL). Methacrolein (38 mL, 0.46 mmol) was
added to the flask and the reaction mixture was stirred for
24 h at ambient temperature. The reaction mixture was
filtered through a short pad of silica gel and the pad
was rinsed with ethyl acetate. The crude reaction mixture
was concentrated in vacuo and then purified by flash
chromatography on silica gel (20% ethyl acetate in hexanes)
to give 55.5 mg (0.20 mmol, 89%) of the product as a light
4. For our work on the synthesis of the Aspidosperma portion,
see: (a) Kozmin, S. A.; Rawal, V. H. J. Am. Chem. Soc. 1998,
120, 13523–13524. (b) Kozmin, S. A.; Iwama, T.; Huang, Y.;
Rawal, V. H. J. Am. Chem. Soc. 2002, 124, 4628–4641. For
other papers on the chemistry of amino siloxy dienes, see:
(c) Kozmin, S. A.; Rawal, V. H. J. Org. Chem. 1997, 62,
5252–5253. (d) Kozmin, S. A.; Rawal, V. H. J. Am. Chem.
Soc. 1997, 119, 7165–7166. (e) Kozmin, S. A.; Janey, J. M.;
Rawal, V. H. J. Org. Chem. 1999, 64, 3039–3052. (f) Kozmin,
S. A.; Green, M. T.; Rawal, V. H. J. Org. Chem. 1999, 64,
8045–8047. (g) Kozmin, S. A.; Rawal, V. H. J. Am. Chem.
Soc. 1999, 121, 9562–9573. (h) Kozmin, S. A.; He, S.; Rawal,
V. H. Org. Synth. 2000, 78, 152. (i) Kozmin, S. A.; He, S.;
Rawal, V. H. Org. Synth. 2000, 78, 160. (j) Janey, J. M.;
Iwama, T.; Kozmin, S. A.; Rawal, V. H. J. Org. Chem. 2000,
65, 9059–9068. (k) Huang, Y.; Rawal, V. H. Org. Lett. 2000,
2, 3321–3323.
1
yellow oil. H NMR (400 MHz, DMSO-d6, 1208C) d (???,
J¼16.0, 8.0 Hz, 2H), 7.19 (t, J¼8.0 Hz, 1H), 7.12 (d,
J¼8.0 Hz, 2H), 6.47 (m, 2H), 4.76 (br d, J¼4 Hz, 1H), 3.45
(br d, J¼8.0 Hz, 1H), 3.06 (br d, J¼8.0 Hz, 1H), 2.92 (m,
1H), 2.09 (dt, J¼12.0, 2.8 Hz, 1H), 1.38 (dd, J¼12.0,
4.0 Hz, 1H), 1.25 (s, 3H); 13C NMR (100 MHz, DMSO-d6,
1208C) d 202.3, 150.9, 134.8, 130.7, 128.3, 124.1, 120.6,
52.1, 50.7, 46.9, 31.3, 30.1, 20.1; enantiomeric excess of the
title compound was determined to be 67% by the Mosher
ester analysis of the corresponding alcohol prepared by
NaBH4 reduction.
5. For 1,2-dihydropyridine possessing a chiral centre:
(a) Matsumura, Y.; Nakamura, Y.; Maki, T.; Onomura, O.
Tetrahedron Lett. 2000, 41, 7685–7689. Dihydropyridine
having
a chiral auxiliary attached to the nitrogen:
(b) Mehmandoust, M.; Marazano, C.; Singh, R.; Gillet, B.;
References
´
Cesario, M.; Fourrey, J.-L.; Das, B. C. Tetrahedron Lett. 1988,
29, 4423–4426. (c) Marazano, C.; Yannic, Y.; Mehmandoust,
M.; Das, B. C. Tetrahedron Lett. 1990, 31, 1995–1998.
Diels–Alder reactions in which the dienophile has a chiral
1. Total syntheses of Iboga alkaloids via the Diels–Alder
reaction of a dihydropyridine with a dienophile. (^)-
Ibogamine: (a) Bu¨chi, G.; Coffen, D. L.; Kocsis, K.; Sonnet,
P. E.; Ziegler, F. E. J. Am. Chem. Soc. 1965, 87, 2073–2075.
(b) Bu¨chi, G.; Coffen, D. L.; Kocsis, K.; Sonnet, P. E.; Ziegler,
F. E. J. Am. Chem. Soc. 1966, 88, 3099–3109. (c) Ikezaki, M.;
Wakamatsu, T.; Ban, Y. J. Chem. Soc., Chem. Commun. 1969,
88–89. (^)-Catharanthine (d) Bu¨chi, G.; Kulsa, P.;
Ogasawara, K.; Rosati, R. L. J. Am. Chem. Soc. 1970, 92,
`
auxiliary: (d) Kouklovsky, C.; Pouilhes, A.; Langlois, Y.
J. Am. Chem. Soc. 1990, 112, 6672–6679. (e) Campbell,
M. M.; Sainsbury, M.; Searle, P. A.; Davis, G. M. Tetrahedron
Lett. 1992, 33, 3181–3184. Selected leading references on the
racemic Diels–Alder reaction of dihydropyridines: (f) Craig,
D.; Kuder, A. K.; Efroymson, J. J. Am. Chem. Soc. 1950, 72,